Logo for Assembly Biosciences Inc

Assembly Biosciences Investor Relations Material

Latest events

Logo for Assembly Biosciences Inc

Investor Update

Assembly Biosciences
Logo for Assembly Biosciences

Q1 2024

8 May, 2024
Logo for Assembly Biosciences

Q4 2023

28 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Assembly Biosciences Inc

Access all reports
Assembly Biosciences, Inc. is a biopharmaceutical company focused on developing small molecule antiviral therapeutics. It is primarily engaged in the discovery and development of treatments targeting hepatitis B virus (HBV) and hepatitis delta virus (HDV), including a portfolio of HBV core inhibitors and other novel antiviral compounds aimed at managing chronic infections. Additionally, the company explores therapies for herpesviruses, with programs advancing long-acting inhibitors and other non-nucleoside polymerase inhibitors intended for transplant-associated infections and other serious disease conditions. Assembly Biosciences is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.